Key result
99m Tc-Duramycin SPECT/CT tracks myocardial cell death in AMI mice, peaking at a ~3.9 uptake ratio.
Why the study?
Non-invasive methods to dynamically monitor myocardial cell death and assess cardioprotective effects of atorvastatin in acute myocardial infarction are needed.
Does atorvastatin reduce myocardial cell death in a mouse model of acute myocardial infarction as assessed by 99m Tc-Duramycin micro-SPECT/CT imaging?
RCT
randomized
Does atorvastatin reduce myocardial cell death in a mouse model of acute myocardial infarction as assessed by 99m Tc-Duramycin micro-SPECT/CT imaging?
99m Tc-Duramycin SPECT/CT imaging allows non-invasive monitoring of myocardial cell death and assessment of atorvastatin's cardioprotective effects in a mouse model of AMI.
Answers are grounded in this paper and cite their sources.
May enable noninvasive tracking of post-AMI apoptosis in models; leaves open clinical translation and statin monitoring.
This study aimed to dynamically monitor myocardial cell death using 99m Tc‐Duramycin single‐photon emission computed tomography/computed tomography (micro‐SPECT/CT) imaging in acute myocardial infarction (AMI) and the anti‐apoptosis effect of atorvastatin for cardioprotection. Mice were randomized into three groups: AMI group, AMI with atorvastatin treatment (T‐AMI) group, and sham group. Three groups of model mice were randomly selected at day 1 (D1), day 3 (D3), and day 7 (D7) day after surgery with 99m Tc‐Duramycin micro‐SPECT/CT imaging. The lesion‐to‐normal myocardial tissue ratio (L/N) average values were 2.62 on D1, 3.89 on D3, and 1.20 on D7 for the uptake of 99m Tc‐duramycin in the infarcted region in the AMI group. The sham group presented no positive imaging in myocardium, and the L/N average values were 1.09, 1.14, and 1.10 on D1, D3, and D7, respectively. Meanwhile, 99m Tc‐linear‐duramycin imaging showed no radioactive uptake in the infarction region. The T‐AMI group imaging showed tracer uptake decreased obviously compared to the uptake in the infarcted region in AMI mice. 99m Tc‐Duramycin SPECT/CT imaging allowed non‐invasive monitoring of myocardial cell death in a mouse model of AMI and an assessment of atorvastatin anti‐apoptosis effect for cardioprotection by in vivo molecular imaging.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2020) conducted an RCT in Acute myocardial infarction. 99m Tc-Duramycin imaging and atorvastatin vs. Sham and AMI without atorvastatin was evaluated on Lesion-to-normal myocardial tissue ratio (L/N) for the uptake of 99m Tc-duramycin. 99m Tc-Duramycin SPECT/CT imaging monitored myocardial cell death in AMI mice, with lesion-to-normal uptake peaking at day 3 and decreasing with atorvastatin.
Synapse has enriched 10 related papers. Consider them for comparative context: